Recently, AXL activity in MM was discovered to be driven by the transcriptional complex SOX2-GLI1 through the sialyltransferase ST3GAL1, which was found to be overexpressed in MM compared to nevi, and in metastatic MM compared to primary MM (14). Here, ST3GAL1 is linked to Miyoshi myopathy.